1.75
2.94%
0.05
After Hours:
1.71
-0.04
-2.29%
Compass Therapeutics Inc stock is traded at $1.75, with a volume of 309.99K.
It is up +2.94% in the last 24 hours and down -9.33% over the past month.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
See More
Previous Close:
$1.70
Open:
$1.7
24h Volume:
309.99K
Relative Volume:
0.72
Market Cap:
$240.78M
Revenue:
-
Net Income/Loss:
$-45.44M
P/E Ratio:
-4.7297
EPS:
-0.37
Net Cash Flow:
$-42.28M
1W Performance:
+2.94%
1M Performance:
-9.33%
6M Performance:
+2.94%
1Y Performance:
-5.91%
Compass Therapeutics Inc Stock (CMPX) Company Profile
Name
Compass Therapeutics Inc
Sector
Industry
Phone
617-500-8099
Address
80 GUEST STREET, BOSTON
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-31-23 | Initiated | Jefferies | Buy |
Jan-27-23 | Initiated | Stifel | Buy |
May-23-22 | Resumed | H.C. Wainwright | Buy |
Mar-15-22 | Initiated | Ladenburg Thalmann | Buy |
Jan-19-22 | Initiated | B. Riley Securities | Buy |
Dec-22-21 | Initiated | Raymond James | Outperform |
Dec-20-21 | Initiated | SVB Leerink | Outperform |
Dec-15-21 | Initiated | Wedbush | Outperform |
View All
Compass Therapeutics Inc Stock (CMPX) Latest News
Treatment Resistant Depression Pipeline Therapeutics, - openPR
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance
Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat
Treatment Resistant Depression Clinical Trials 2024: FDA - openPR
Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News
Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex
CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle
Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World
JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World
Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR
Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com
Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire
Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News
American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat
Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World
Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World
Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World
NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World
PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World
Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World
Gencor Industries, Inc. (NASDAQ:GENC) Shares Acquired by Renaissance Technologies LLC - Defense World
First Trust Cloud Computing ETF (NASDAQ:SKYY) Sets New 52-Week High at $103.17 - Defense World
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News
Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle
TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail
Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World
Invesco Plc (IVZ-N) QuotePress Release - The Globe and Mail
Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World
Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World
A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News
Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN
Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World
Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada
Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat
Executive team - Compass Pathways
National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World
Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex
Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World
Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World
Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World
Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World
Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World
Compass Therapeutics Inc Stock (CMPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):